The trend towards increasing specialisation within MBAs continues to gather pace with the Macquarie Graduate School of Management (MGSM) unveiling a new elective focussing on leadership and management issues specific to the health care sector.
The unit will be led by MGSM’s Graham Millett and has been developed in collaboration with Professor Mark Compton AM. Professor Compton is the CEO of St Luke’s Care, Vice Chancellor and non-executive director of St John Ambulance Australia and a non-executive director of Macquarie University Hospital.
The first class will commence in September and will be delivered by key industry leaders including: Chris Rex, CEO of Ramsay Health Care; Chris Roberts, CEO of Cochlear; Steven Rubic, CEO of I-MED Network Radiology; Dr Rachel David, Healthcare and Public Sector, McKinsey & Company; Michael Roff, CEO of APHA; Wayne Cahill, Partner at Ashurst and Evan Rawstron, COO, Macquarie University Hospital.
MGSM’s Interim Dean, Associate Professor Guy Ford said: “For some time a significant proportion of participants in the school’s programs have come from the health care sector and while strategy, change management and leadership are common across all sectors, the heath care sector faces specific challenges around these items that are sufficient to warrant a specific and deeper focus.”
Professor Compton said MGSM was well placed to provide the course due to its physical proximity to many health care, life science, pharmaceutical and medical device organisations and also its relationship with the Australian School of Advanced Medicine at Macquarie University.
“Due to Australia’s ageing population and the increasing demand on health care services, along with tight government budgets and the continuing global economic conditions it is critical that we offer further specific training and education to our current and future health care leaders and managers,” Professor Compton said. “This will make a very significant contribution to securing a strong and stable future for the sector.”
Other than MGSM MBA students, the unit is open to MGSM alumni and industry professionals who may wish to participate. As part of the assessment, participants will work on a project developed in conjunction with the presenters and supported by an advisory committee of experts in the field. This approach is complemented by MGSM’s current Living Case Study with Pfizer Oncology.
